文献速递免疫规划传染病防控与疫情报告

生淀粉微粒作为BCG佐剂:其效力取决于感染菌株的毒力

Raw starch microparticles as BCG adjuvant: Their efficacy depends on the virulence of the infection strains.
PubMed 文献 · Vaccine · 2019-04-15

本研究在小鼠模型中测试将生淀粉微粒(SMPs)作为BCG疫苗佐剂,经皮下接种后以强毒力结核分枝杆菌攻击,评估其对疫苗保护效力的增强作用。结果显示SMPs的佐剂活性依赖于感染菌株的毒力,并证实该碳水化合物佐剂不仅适用于黏膜途径,也适用于胃肠外接种策略。

要点

  • SMPs作为BCG佐剂经皮下接种可增强疫苗保护效力,但效果取决于攻击菌株毒力。
  • SMPs的佐剂活性在黏膜和胃肠外接种策略中均得到验证。
  • 菌株毒力是影响SMPs佐剂活性的关键因素。

核心结论

  • SMPs作为BCG全细胞疫苗佐剂经皮下接种,其增强保护效力的作用依赖于感染菌株的毒力。
  • SMPs的佐剂活性在不同接种策略(黏膜与胃肠外)中均得到证实。

研究设计与样本

  • 在BCG初免的BALB/c小鼠中,将SMPs作为佐剂加入BCG全细胞疫苗经皮下接种,随后用强毒力结核分枝杆菌菌株攻击。

主要发现

  • SMPs的佐剂效果因感染菌株不同而异,表明毒力是影响其佐剂活性的关键因素。
  • SMPs作为碳水化合物佐剂在胃肠外接种策略中同样具有佐剂活性。

临床怎么用

  • SMPs可作为BCG疫苗的候选佐剂,但需考虑流行菌株毒力对佐剂效果的影响。
  • SMPs佐剂可应用于黏膜和胃肠外接种策略,为疫苗设计提供灵活选择。

局限性

  • 研究仅在小鼠模型中进行,结果尚未在人体中验证。
  • 佐剂效果受感染菌株毒力影响,提示其适用性可能因流行菌株而异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The persistence of tuberculosis (TB) as one of the top 10 causes of death worldwide, the growing incidence of multidrug-resistant tuberculosis and the controversial efficacy of the Bacille Calmette-Guérin (BCG) vaccine drives the development of new generation multistage vaccines against this disease that can boost BCG-primed immunity. The use of polymeric microparticles for this purpose increases due to their advantages, especially their good safety levels and intrinsic immunostimulant properties. We recently explored and demonstrated the reinforcing and adjuvant potential of starch microparticles (SMPs) that administered intranasally to BCG-primed BALB/c mice, alone or in combination with a recombinant antigen, increased survival rates and induced a reduction of bacterial load in the lungs of mice infected with tuberculosis. Here, we tested the effect of SMPs added to the BCG vaccine as adjuvant to the whole-cell vaccine and investigated their contribution to the improvement of the protective efficacy of subcutaneous vaccination in mice challenged with virulent strains of Mycobacterium tuberculosis. As expected, our results were dependent on the infection strains, showing that virulence is a crucial factor that affects the adjuvant activity of SMPs. Our results also confirm the adjuvant activity of this carbohydrate and its usefulness in diverse vaccination strategies not only for mucosal but also for parenteral administration.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Moreno-Mendieta S, Barrera-Rosales A, Mata-Espinosa D, et al. Raw starch microparticles as BCG adjuvant: Their efficacy depends on the virulence of the infection strains. Vaccine. 2019. PMID: 31000412. doi:10.1016/j.vaccine.2019.04.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。